As much as 70% of breast cancers are associated with a hyperactive PI3K/AKT pathway [4, 5] and activated AKT modulates the function of numerous substrates involved in the regulation of cell survival, cell cycle progression and cellular growth [6]. This evidence concerns the gene AKT1 and breast carcinoma.